Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufact… recall
FDA recall D-0724-2026 · initiated Jul 13, 2026
Rising Pharma Holding, Inc. recalled Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only… in Jul 2026 — an FDA Class II recall (D-0724-2026) because Presence of Precipitate: medication was crystallizing and particles floating in the bottle.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
Wrong strength, or it did not keep
The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 74208 units
Details
- Product
- Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.
- Recalling company
- Rising Pharma Holding, Inc.
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide U.S.A.
- Initiated
- Jul 13, 2026
- FDA report date
- Jul 29, 2026
Frequently asked
- Was Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only… recalled?
- Rising Pharma Holding, Inc. recalled Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only… in Jul 2026 — an FDA Class II recall (D-0724-2026) because Presence of Precipitate: medication was crystallizing and particles floating in the bottle. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only… recalled?
- Per the FDA enforcement record, the reason for recall D-0724-2026 was: Presence of Precipitate: medication was crystallizing and particles floating in the bottle
- Is a recalled Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only… dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only… are affected?
- Distributed: Nationwide U.S.A.. The recall covers these lots — Lots: Batch # CR2518, Exp. 11/2027; Batch # CR2601, Exp. 12/2027; CR2602, CR2603, Exp. 01/2028; CR2604, CR2605, Exp. 02/2028.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0724-2026.